The role of peptides derived from Spirulina maxima in downregulation of FcεRI-mediated allergic responses

Molecular Nutrition and Food Research

Volumn 58, Issue 11, 2014, Pages 2226-2234

  Vo, Thanh Sang ^a   Ngo, Dai Hung ^a   Kang, Kyong Hwa ^a   Park, Sun Joo ^a   Kim, Se Kwon ^a  

^a Pukyong National University   (South Korea)

Author keywords

Allergic reaction; Fc RI; Histamine; IL 4; Spirulina maxima

Indexed keywords

SPIRULINA; SPIRULINA MAXIMA;

ALLERGEN; ANTIALLERGIC AGENT; FCEPSILONRI PROTEIN, RAT; HISTAMINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 4; PEPTIDE; PHOSPHOLIPASE C GAMMA; REACTIVE OXYGEN METABOLITE;

ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; DOWN REGULATION; DRUG EFFECTS; GENETICS; HISTAMINE RELEASE; HYPERSENSITIVITY; IMMUNOLOGY; MAST CELL; METABOLISM; MOLECULAR DOCKING; RAT; SIGNAL TRANSDUCTION; SPIRULINA; TUMOR CELL LINE;

ALLERGENS; ANIMALS; ANTI-ALLERGIC AGENTS; CELL LINE, TUMOR; DOWN-REGULATION; HISTAMINE; HISTAMINE RELEASE; HYPERSENSITIVITY; IMMUNOGLOBULIN E; INTERLEUKIN-4; MAST CELLS; MOLECULAR DOCKING SIMULATION; NF-KAPPA B; PEPTIDES; PHOSPHOLIPASE C GAMMA; RATS; REACTIVE OXYGEN SPECIES; RECEPTORS, IGE; SIGNAL TRANSDUCTION; SPIRULINA;

EID: 84922829370     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201400329     Document Type: Article

References (39)

1. Galli, S. J., Tsai, M., Piliponsky, A. M., The development of allergic inflammation. Nature 2008, 454, 445-454.
2. Arshad, S. H., Does exposure to indoor allergens contribute to the development of asthma and allergy? Curr. Allergy Asthm. Rep. 2010, 10, 49-55.
3. Brown, J. M., Wilson, T. M., Metcalfe, D. D., The mast cell and allergic diseases: role in pathogenesis and implications for therapy. Clin. Exp. Allergy 2008, 38, 4-18.
4. Abramson, J., Pecht, I., Regulation of the mast cell response to the type I Fcε receptor. Immunol. Rev. 2007, 217, 231-254.
5. Gilfillan, A. M., Tkaczyk, C., Integrated signalling pathways for mast-cell activation. Nat. Rev. Immunol. 2006, 6, 218-230.
6. Turner, H., Kinet, J. P., Signalling through the high-affinity IgE receptor Fc epsilonRI. Nature 1999, 402, B24-B30.
7. Ciferri, O., Spirulina, the edible microorganism. Microbiol. Rev. 1983, 47, 551-578.
8. Khan, Z., Bhadouria, P., Bisen, P. S., Nutritional and therapeutic potential of Spirulina. Curr. Pharm. Biotechnol. 2005, 6, 373-379.
9. Chamorro, G., Salazar, M., Araujo, K. G., dos Santos, C. P. et al., Update on the pharmacology of Spirulina (Arthrospira), an unconventional food. Arch. Latinoam. Nutr. 2002, 52, 232-240.
10. Cingi, C., Conk-Dalay, M., Cakli, H., Bal, C., The effects of Spirulina on allergic rhinitis. Eur. Arch. Otorhinolaryngol. 2008, 265, 1219-1223.
11. Yang, H. N., Lee, E. H., Kim, H. M., Spirulina platensis inhibits anaphylactic reaction. Life Sci. 1997, 61, 1237-1244.
12. Ngo, D. H., Vo, T. S., Ngo, D. N., Wijesekara, I. et al., Biological activities and potential health benefits of bioactive peptides derived from marine organisms. Int. J. Biol. Macromol. 2012, 51, 378-383.
13. Schlimme, E., Meisel, H., Bioactive peptides derived from milk proteins. Structural, physiological and analytical aspects. Food/Nahrung 1995, 39, 1-20.
14. Dziuba, J., Minkiewicz, P., Nałecz, D., Iwaniak, A., Database of biologically active peptide sequences. Food/Nahrung 1999, 43, 190-195.
15. Vo, T. S., Ryu, B. M., Kim, S. K., Purification of novel anti-inflammatory peptides from enzymatic hydrolysate of the edible microalgal Spirulina maxima. J. Funct. Foods 2013, 5, 1336-1346.
16. Vo, T. S., Kong, C. S., Kim, S. K., Inhibitory effects of chitooligosaccharides on degranulation and cytokine generation in rat basophilic leukemia RBL-2H3 cells. Carbohydr. Polym. 2011, 84, 649-655.
17. Himaya, S. W., Dewapriya, P., Kim, S. K., EGFR tyrosine kinase inhibitory peptide attenuates Helicobacter pylori-mediated hyper-proliferation in AGS enteric epithelial cells. Toxicol. Appl. Pharmacol. 2013, 269, 205-214.
18. Vo, T. S., Kim, S. K., Down-regulation of histamine-induced endothelial cell activation as potential anti-atherosclerotic activity of peptides from Spirulina maxima. Eur. J. Pharm. Sci. 2013, 50, 198-207.
19. Marshall, J. S., Mast-cell responses to pathogens. Nat. Med. 2004, 4, 787-799.
20. Yoko, M. K., Yoshio, H., Tetsuya, A., Satsuki, I. S. et al., The control effect of histamine on body temperature and respiratory function in IgE-dependent systemic anaphylaxis. J. Allergy Clin. Immunol. 2002, 110, 298-303.
21. Nishida, K., Yamasaki, S., Ito, Y., Kabu, K. et al., FcεRI-mediated mast cell degranulation requires calcium-independent microtubule-dependent translocation of granules to the plasma membrane. J. Cell Biol. 2005, 170, 115-126.
22. Smith, A. J., Pfeiffer, J. R., Zhang, J., Martinez, A. M. et al., Microtuble-dependent transport of secretory vesicles in RBL-2H3 cells. Traffic 2003, 4, 302-312.
23. Martin-Verdeaux, S., Pombo, I., Iannascoli, B., Roa, M. et al., Evidence of a role for Munc18-2 and microtubules in mast cell granule exocytosis. J. Cell Sci. 2003, 116, 325-334.
24. Blank, U., Rivera, J., The ins and outs of IgE-dependent mast-cell exocytosis. Trends Immunol. 2004, 25, 266-273.
25. Aketani, S., Teshima, R., Umezawa, Y., Sawada, J., Correlation between cytosolic calcium concentration and degranulation in RBL-2H3 cells in the presence of various concentrations of antigen-specific IgEs. Immunol. Lett. 2001, 75, 185-189.
26. Kim, K., Kim, Y., Kim, H. Y., Ro, J. Y., Jeoung, D., Inhibitory mechanism of anti-allergic peptides in RBL-2H3 cells. Eur. J. Pharmacol. 2008, 581, 191-203.
27. 2+ influx. Biochem. Pharmacol. 1998, 55, 1255-1262.
28. Siraganian, R. P., Mast cell signal transduction from the high-affinity IgE receptor. Curr. Opin. Immunol. 2003, 15, 639-646.
29. Suzuki, Y., Yoshimaru, T., Inoue, T., Niide, O., Ra, C., Role of oxidants in mast cell activation. Chem. Immunol. Allergy 2005, 87, 32-42.
30. Camello-Almaraz, C., Gomez-Pinilla, P. J., Pozo, M. J., Camello, P. J., Mitochondrial reactive oxygen species and Ca2+ signaling. Am. J. Physiol. Cell Physiol. 2006, 291, C1082-C1088.
31. Yamashita, K., Suzuki, Y., Matsui, T., Yoshimaru, T. et al., Epigallocatechin gallate inhibits histamine release from rat basophilic leukemia (RBL-2H3) cells: role of tyrosine phosphorylation pathway. Biochem. Biophys. Res. Commun. 2000, 274, 603-608.
32. Yoshimaru, T., Suzuki, Y., Matsui, T., Yamashita, K. et al., Blockade of superoxide generation prevents high-affinity immunoglobulin E receptor-mediated release of allergic mediators by rat mast cell line and human basophils. Clin. Exp. Allergy 2002, 32, 612-618.
33. Levine, R. L., Mosoni, L., Berlett, B. S., Stadtman, E. R., Methionine residues as endogenous antioxidants in proteins. Proc. Natl. Acad. Sci. USA 1996, 93, 15036-15040.
34. Dorozhko, E. V., Korotkova, E. I., Antioxidant properties of sulfur-containing biologically active substances studied by voltammetric and spectrophotometric techniques. Pharm. Chem. J. 2011, 44, 851-854.
35. Horsmanheimo, L., Harvima, I. T., Järvikallio, A., Harvima, R. J. et al., Mast cells are one major source of interleukin-4 in atopic dermatitis. Br. J. Dermatol. 1994, 131, 348-353.
36. Nabeshima, Y., Hiragun, T., Morita, E., Mihara, S. et al., IL-4 modulates the histamine content of mast cells in a mast cell/fibroblast coculture through a Stat6 signaling pathway in fibroblasts. FEBS Lett. 2005, 579, 6653-6658.
37. Hayden, M. S., Ghosh, S., Signaling to NF-kappaB. Genes Dev. 2004, 18, 2195-2224.
38. Takatsuna, H., Morita, S., Nagatsu, T., Sawada, M. et al., Inhibition of inflammatory cytokine secretion from mouse microglia cells by DHMEQ, an NF-κB inhibitor. Biomed. Pharmacother. 2005, 59, 318-322.
39. Gloire, G., Legrand-Poels, S., Piette, J., NF-kappaB activation by reactive oxygen species: fifteen years later. Biochem. Pharmacol. 2006, 72, 1493-1505.